of Absorv Bioabsorbables include modulated degradation rates, varying strengths and stiffness, and FDA approval for medical devices. Zeus is currently processing these materials and providing multiple extrusion forms, such as shapes, special profiles, and multi-lumens. The product offering also includes precision tubing ranging from outer diameters of 0.012in to 0.250in and tolerances as tight as +\- 0.0005in; monofilament ranging from diameters of 0.003in to 0.060in; tape/ribbon; rod stock; and compounded pellet form. Zeus also provides absorbable polymers as cast films and non-woven microporous sheets.
About Zeus, Inc.:
Zeus, Inc. is headquartered in Orangeburg, SC USA. Zeus is a world leader in material science and the production of high-performance polymer tubing used in demanding applications, operating multiple facilities in North America and internationally. Zeus products and services are preferred by companies in medical, automotive, electrical, fluid handling and mechanical markets. For more information, visit http://www.zeusinc.com.
Press Contact:
Samantha Farlow
Communications Coordinator
(803) 268-9500
publicrelations@zeusinc.com
This release was issued through eReleases(TM). For more information, visit http://www.ereleases.com.
SOURCE Zeus, Inc.
'/>"/>SOURCE Zeus, Inc. Copyright©2009 PR Newswire. All rights reserved | |
Page: 1 2 Related biology technology :1.
UCSF and YouTube Launch Channel Dedicated to Educating the Public About Neurodegenerative Diseases2.
First Seed Sales of Dedicated Energy Crops Begin3.
Neurosurgery Journal Issues Supplement Dedicated to CyberKnife Radiosurgery Experience4.
MedImmune Strengthens Key Leadership Functions to Further Support Recently Expanded, Rapidly Advancing Product Portfolio5.
American Psychiatric Foundation Announces Recipients of 2008 Awards for Advancing Minority Mental Health6.
International Society for Stem Cell Research Applauds Outcome of Proposal 2 Advancing Stem Cell Research7.
CFSO Calls for Roundtable to Develop National Strategy for Advancing Forensic Sciences in the United States8.
Nuclear fusion research key to advancing computer chips9.
National Stem Cell Holding Announces Patent Application for Newly Discovered Cellular Derived Biomaterials for Anti-Aging Applications10.
National Stem Cell Holding in Final Stage Negotiations for Exclusive Licensing of its Recently Discovered Biomaterial for Anti-Aging Applications11.
LeMaitre Vascular Acquires Biomateriali, a Vascular Graft Manufacturer